I reviewed the RESA website. They have a
homogeneous proprietary plan using software, an
algorithm, a technician and a scanning method
developed by a cyclist + engineers to create what
they value as a $199 product. Remember the Soles
3-D printed orthotics that DPMs were dispensing
that is now out of business having lost $30
million.

I welcome the competition from Costco that will
help educate the foot and postural suffering
public towards the need for customized orthotic
props. My insult comes from Costco stating that
the DPM product is worth $300 when mine are $950.

Orthotic authorities lack consensus but state that
subtalar joint neutral casting is not enough.
State that a thorough exam and diagnosis is
imperative. State that add-ons to the shell must
be incorporated for custom device excellence:
https://www.podiatrytoday.com/current-insights-
neutral-casting-and-biomechanical-exams-orthotic-
prescriptions

My opinion is that the RESA product is competitive
to most STJ Neutral cast, post to cast podiatry
products. This holds true when taken by staff and
not the DPM and not prompted by a modern bioeval.

Podiatry orthotics have stagnated for decades. The
competition has gotten better. No customized
insole has evidence to back up marketing claims as
to usefulness and value. That is the milieu of
this discussion

Podiatry needs to offer more than the fact that
our orthotics are being dispensed by a licensed
professional. We need to find a way to make our
biomechanics and orthotics great again rather than
try to eliminate the competition as suggested.

Dennis Shavelson, DPM, NY, NY